Expert Discusses KRAS G12C Inhibitors for Patients with NSCLCByBob T. Li, MD, MPHNovember 18th 2019Future treatment for patients with the KRAS G12C mutation in NSCLC shows potential promise, according to a principal investigator studying the AMG 510 inhibitor.